AI assistant
Sending…
RESMED INC — Director's Dealing 2023
Feb 17, 2023
30071_dirs_2023-02-16_8c0fafb0-6d01-4b79-b84d-5fcd1e066861.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2023-02-15
Reporting Person: Douglas Robert Andrew (President and COO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-02-15 | ResMed Common Stock | S | 1500 | $213.50 | Disposed | 261445 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| ResMed Common Stock | 16819 | Direct |
Footnotes
F1: The transaction was conducted under a Rule 10b5-1 plan.
F2: Includes a transfer of shares between direct and indirect holdings on 2/8/2023.
More from RESMED INC
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Regulatory Filings
2026
Jan 29
Director's Dealing
2026
Jan 9